tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

MDGL Stock Latest News

Akero cirrhosis data positive for Madrigal, says Piper Sandler
The FlyAkero cirrhosis data positive for Madrigal, says Piper Sandler
5d ago
MDGL
Madrigal dip on Akero data a buying opportunity, says Evercore ISI
PremiumThe Fly
Madrigal dip on Akero data a buying opportunity, says Evercore ISI
5d ago
AKRO
MDGL
Madrigal Pharmaceuticals’ Treatment Could Be a Blockbuster in the Making
PremiumMarket News
Madrigal Pharmaceuticals’ Treatment Could Be a Blockbuster in the Making
12d ago
MDGL
Madrigal Pharmaceuticals price target raised to $392 from $360 at Evercore ISI
PremiumThe Fly
Madrigal Pharmaceuticals price target raised to $392 from $360 at Evercore ISI
17d ago
MDGL
Madrigal price target raised to $400 from $390 at H.C. Wainwright
PremiumThe Fly
Madrigal price target raised to $400 from $390 at H.C. Wainwright
19d ago
MDGL
Madrigal Pharmaceuticals price target lowered to $154 from $155 at BofA
PremiumThe FlyMadrigal Pharmaceuticals price target lowered to $154 from $155 at BofA
19d ago
MDGL
Madrigal Pharmaceuticals sees Q4 Rezdiffra revenue $100M-$103M
Premium
The Fly
Madrigal Pharmaceuticals sees Q4 Rezdiffra revenue $100M-$103M
20d ago
MDGL
Oppenheimer starts Sagimet with Outperform on ‘underappreciated opportunity’
Premium
The Fly
Oppenheimer starts Sagimet with Outperform on ‘underappreciated opportunity’
2M ago
MDGL
SGMT
Madrigal Pharmaceuticals price target raised to $427 from $415 at JMP Securities
PremiumThe Fly
Madrigal Pharmaceuticals price target raised to $427 from $415 at JMP Securities
2M ago
MDGL
Madrigal Pharmaceuticals price target raised to $400 from $350 at Oppenheimer
PremiumThe Fly
Madrigal Pharmaceuticals price target raised to $400 from $350 at Oppenheimer
2M ago
MDGL
Paulson takes new stake in Southwestern Energy, exits AngloGold Ashanti
PremiumThe Fly
Paulson takes new stake in Southwestern Energy, exits AngloGold Ashanti
3M ago
AU
ATUS
Madrigal Pharmaceuticals price target raised to $236 from $194 at B. Riley
PremiumThe Fly
Madrigal Pharmaceuticals price target raised to $236 from $194 at B. Riley
3M ago
MDGL
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
3M ago
NVO
VIR
Madrigal, 89Bio jump after Novo’s semaglutide shows promise in MASH
Premium
The Fly
Madrigal, 89Bio jump after Novo’s semaglutide shows promise in MASH
3M ago
NVO
AKRO
Madrigal Pharmaceuticals price target raised to $441 from $411 at UBS
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $441 from $411 at UBS
3M ago
MDGL
Madrigal Pharmaceuticals Reports Strong Rezdiffra Launch
PremiumCompany Announcements
Madrigal Pharmaceuticals Reports Strong Rezdiffra Launch
3M ago
MDGL
Madrigal Pharmaceuticals price target raised to $394 from $377 at Canaccord
PremiumThe Fly
Madrigal Pharmaceuticals price target raised to $394 from $377 at Canaccord
3M ago
MDGL
Madrigal Pharmaceuticals reports Q3 EPS ($4.92), consensus ($6.91)
PremiumThe Fly
Madrigal Pharmaceuticals reports Q3 EPS ($4.92), consensus ($6.91)
3M ago
MDGL
Madrigal Pharmaceuticals to present multiple resmetirom data presentations
PremiumThe Fly
Madrigal Pharmaceuticals to present multiple resmetirom data presentations
3M ago
MDGL
MDGL Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsMDGL Upcoming Earnings Report: What to Expect?
3M ago
MDGL
Madrigal Pharmaceuticals price target lowered to $350 from $375 at Oppenheimer
Premium
The Fly
Madrigal Pharmaceuticals price target lowered to $350 from $375 at Oppenheimer
3M ago
MDGL
3 Best Stocks to Buy Now, 10/23/2024, According to Top Analysts 
Premium
Market News
3 Best Stocks to Buy Now, 10/23/2024, According to Top Analysts 
3M ago
CROX
MDGL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >